News – Page 91 – Endpoints News

Roche, Genentech end anti-tau Alzheimer’s drug collaboration with UCB

7 months ago

AvenCell gets $112M to build switchable CAR-T therapies for ‘the last frontier’ of blood cancers

7 months ago

Biden administration calls for expanded contraception coverage

7 months ago

Lilly files more lawsuits over sales of copycat Zepbound

7 months ago

Starboard takes activist stake in J&J consumer spinout Kenvue

7 months ago

FDA to launch pilot project for more transparency on generic drug delays

7 months ago

AstraZeneca-backed CDMO Nucleus RadioPharma to boost commercial capacity

7 months ago

Gilead, Merck's experimental long-acting HIV treatment heads to Phase 3

7 months ago

Regenxbio shares new mid-stage data for its wet AMD gene therapy

7 months ago

Nurix says protein degrader shows potential in Waldenstrom’s patients in early trial

7 months ago

GSK to put £50M into Cambridge University partnership; Angelini’s new deal

7 months ago

Q3 biotech roundup: The 2024 turnaround sputters into a critical Q4 finale

7 months ago

Novo declares Phase 3 cardiac outcomes trial win for oral GLP-1

7 months ago

Septerna outlines $157M IPO after entering the clinic with GPCR pipeline

7 months ago

Catalent moves to reassure customers about what happens after merger

7 months ago

Former Karuna crew quickly assembles $225M for next neuro bet at Seaport

7 months ago

Vertex shares full pivotal non-opioid pain data, showing better safety than placebo

7 months ago

A Q&A with a Nobel Prize winner; Pfizer meets with Starboard; J&J reports Q3 earnings; and more

7 months ago

NJ judge tosses Novartis' IRA lawsuit in another win for government

7 months ago

Lykos is optimistic about MDMA treatment after meeting with FDA

7 months ago

FDA won't take action against GLP-1 compounders as it rethinks tirzepatide shortage

7 months ago

FDA approves Astellas' gastric cancer drug Vyloy ahead of schedule

7 months ago

Apertura and Atalanta reduce headcount en route toward the clinic

7 months ago

EMA again recommends against authorization for PTC Therapeutics' Translarna

7 months ago

First page Previous page 88 89 909192 93 94 Next page Last page